(S)-(3-Hydroxy-3-(piperidin-2-yl)azetidin-1-yl)(2,3,4-trifluorophenyl)methanone hydrochloride, 97%, 100mg

7-Bromo-2-methylimidazo[1,2-a]pyridin-3-amine, 97%, 100mg

1-Butoxy-2,3-difluorobenzene>98.0%(GC)5g

Flat flange reaction vessel cylindrical, graduated (2) Flat bottom, DN 100, 160 mm, Height, 300 mm, 1 Piece

Fmoc-N-(propargyl)-glycine, 99.0%, 250mg

1H-PYRROLO[2,3-C]PYRIDINE-4-CARBOXYLIC ACID, 95.0%, 250mg

N-(5-(4-(tert-Butyl)phenyl)-1,3,4-thiadiazol-2-yl)propionamide, 98%, 100mg

Propanamide, N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-2-thiazolyl]-1-pyrrolidinyl]-2-oxoethyl]-2-(methylamino)-, (2S)-, 99%, 1mg

5-Chloro-2-methylaniline, 99.0%, 1g

5-Fluoro-2-methylbenzoic Acid>98.0%(GC)25g

3-ethyl-1,2,4-oxadiazol-5-ol, 95.0%, 5g

6-chloro-2,3,4,9-tetrahydro-1H-beta-carbolin-1-one, 100mg

1H-Pyrrole-2,5-dimethanol, 98%, 250mg